Top compounds associated with response to CD19


Feature Type Standardized
Nominal ANOVA
mRNA Vorinostat gCSI pan-cancer AAC 0.074 0.2
mRNA Docetaxel gCSI pan-cancer AAC 0.066 0.3
mRNA paclitaxel gCSI pan-cancer AAC 0.044 0.5
mRNA lapatinib gCSI pan-cancer AAC -0.0079 0.9
mRNA Erlotinib gCSI pan-cancer AAC -0.0016 1
mRNA MS-275 gCSI pan-cancer AAC 0.00096 1
Download CSV